Kaushik Banerjee Selected Research

Kaushik Banerjee Research Topics

Disease

25	Neoplasms (Cancer) 03/2024 - 05/2011
10	Ascites 10/2021 - 09/2011
10	Carcinoma (Carcinomatosis) 10/2021 - 09/2011
8	Glioma (Gliomas) 03/2024 - 01/2021
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2016 - 05/2011
3	Poliomyelitis (Polio) 04/2003 - 01/2002
2	Brain Neoplasms (Brain Tumor) 06/2023 - 01/2021
2	Leukemia 12/2016 - 02/2014
1	Metabolic Diseases (Metabolic Disease) 12/2023
1	Inflammation (Inflammations) 01/2023
1	Rheumatic Diseases (Rheumatism) 01/2023
1	Bites and Stings (Sting) 11/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Mycoses (Diseases, Fungus) 11/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 08/2017
1	Breast Neoplasms (Breast Cancer) 03/2017
1	Malaria 01/2017
1	Measles 01/2017
1	Melanoma (Melanoma, Malignant) 01/2017
1	Dehydration (Water Stress) 01/2017
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Adenocarcinoma of Lung 01/2017
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 12/2016
1	Bacterial Infections (Bacterial Infection) 09/2013
1	Necrosis 01/2012
1	Paralysis (Palsy) 01/2002

Drug/Important Bio-Agent (IBA)

9	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 09/2011
6	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2017 - 05/2011
5	Proteins (Proteins, Gene)FDA Link 03/2024 - 05/2011
5	Schiff Bases (Schiff Base)IBA 12/2017 - 01/2014
5	Glutathione (Reduced Glutathione)IBA 03/2017 - 01/2012
5	CopperIBA 12/2016 - 05/2011
3	Antineoplastic Agents (Antineoplastics)IBA 12/2017 - 08/2017
3	Annexin A5IBA 01/2017 - 06/2013
3	VaccinesIBA 01/2017 - 01/2002
2	RNA (Ribonucleic Acid)IBA 03/2024 - 06/2023
2	Small Interfering RNA (siRNA)IBA 03/2024 - 01/2023
2	Histones (Histone)IBA 06/2023 - 01/2021
2	CytokinesIBA 11/2022 - 01/2021
2	LigandsIBA 01/2022 - 12/2016
2	Hydroxamic Acids (Hydroxamic Acid)IBA 10/2021 - 02/2014
2	ZincIBA 12/2017 - 11/2011
2	ManganeseIBA 03/2017 - 07/2013
2	Methylnitronitrosoguanidine (MNNG)IBA 03/2017 - 07/2013
2	catalase-polyethylene glycolIBA 12/2016 - 01/2012
2	MetalsIBA 01/2014 - 11/2011
2	multidrug resistance-associated protein 1IBA 02/2012 - 01/2012
1	Endocrine DisruptorsIBA 12/2023
1	Grape Seed ExtractIBA 01/2023
1	AGI-5198IBA 01/2023
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023
1	ChromatinIBA 01/2023
1	Methotrexate (Mexate)FDA LinkGeneric 01/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 11/2022
1	DNA (Deoxyribonucleic Acid)IBA 11/2022
1	ChemokinesIBA 01/2022
1	antiglomerular basement membrane antibodyIBA 01/2022
1	diphenyl (biphenyl)IBA 10/2021
1	TinIBA 10/2021
1	oxalyl bis(N-phenyl)hydroxamic acidIBA 10/2021
1	Matrix Metalloproteinases (MMPs)IBA 10/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	epidermal growth factor receptor VIIIIBA 01/2021
1	ProdrugsIBA 01/2021
1	MycotoxinsIBA 11/2019
1	AntioxidantsIBA 01/2019
1	GoldIBA 01/2019
1	ElementsIBA 12/2017
1	Cysteine (L-Cysteine)FDA Link 12/2017
1	NickelIBA 12/2017
1	VanadiumIBA 08/2017
1	Vanadates (Orthovanadate)IBA 08/2017
1	CaspasesIBA 08/2017
1	AntigensIBA 01/2017
1	Immunologic Factors (Immunomodulators)IBA 09/2014
1	beta-(5-hydroxy-2-pyridyl)alanineIBA 01/2014
1	Phosphotransferases (Kinase)IBA 01/2014
1	Alanine (L-Alanine)FDA Link 01/2014
1	cupric chloride (copper(II) chloride)FDA Link 01/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2013
1	Caspase 3 (Caspase-3)IBA 06/2013
1	acetophenoneIBA 06/2013
1	IronIBA 02/2012
1	quinolineIBA 09/2011

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 12/2017 - 11/2011
4	Therapeutics 01/2023 - 09/2014
4	Immunotherapy 01/2022 - 01/2021
2	Radiotherapy 01/2023 - 01/2022
1	Chemoprevention 12/2017
1	Fluid Therapy (Oral Rehydration Therapy) 01/2017
1	Injections 04/2003